Vancouver, British Columbia – Might 6, 2022 (Newsfile Corp.) (Investorideas.com Newswire) Emerald Well being Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) (“Emerald” or the “Firm”) introduced in the present day that it has transferred its US itemizing to the OTCQB after receiving discover from the OTC Markets Group that the Firm not meets the itemizing necessities for continued itemizing on the OTCQX Worldwide tier.
On November 3, 2021, Emerald obtained discover that the Firm’s bid value had closed under $0.10 for greater than 30 consecutive calendar days and not met the Requirements for Continued Qualification for the OTCQX Worldwide tier. The OTC Markets Group supplied Emerald a remedy interval of 180 calendar days to have its share value shut at US$0.10 or above for ten consecutive buying and selling days. On Might 4, 2022, the OTC Markets Group knowledgeable the Firm that it didn’t meet the factors to proceed its OTCQX Worldwide Itemizing.
The OTC Markets Group invited Emerald to use to record on the OTCQB, the place the Firm continued to fulfill the related itemizing necessities. The Firm filed its OTCQB software to switch its itemizing on Might 5, 2022, and the Firm will start buying and selling on the OTCQB at market-open in the present day underneath the identical image: EMHTF.
Please go to www.emeraldhealth.ca for extra data or contact:
Mohammed Jiwan , Chief Working Officer
1(800) 757 3536 Ext. #5
Emerald Investor Relations
(800) 757 3536 Ext. #5
make [email protected]
Neither the Canadian Securities Alternate nor the Market Regulator (as that time period is outlined within the insurance policies of the Canadian Securities Alternate) accepts accountability for the adequacy or accuracy of this launch.
Cautionary Notice Concerning Ahead-Trying Statements: Sure statements made on this press launch that aren’t historic information are forward-looking statements and are topic to vital dangers, uncertainties and assumptions, each basic and particular, which give rise to the likelihood that precise outcomes or occasions may differ materially from our expectations expressed in or implied by such forward-looking statements.
We can not assure that any forward-looking assertion will materialize, and readers are cautioned to not place undue reliance on these forward-looking statements. These statements should not historic information however as an alternative signify administration beliefs concerning future occasions, lots of which, by their nature are inherently unsure and past administration management.
The forward-looking statements contained on this press launch signify our expectations as of the date hereof. Ahead-looking statements are offered for the aim of offering details about administration’s present expectations and plans and permitting traders and others to acquire a greater understanding of our anticipated working atmosphere. Readers are cautioned that such data is probably not applicable for different functions. Emerald undertakes no obligations to replace or revise such statements to replicate new circumstances or unanticipated occasions as they happen until required by relevant regulation.
Disclaimer/Disclosure: Investorideas.com is a digital writer of third occasion sourced information, articles and fairness analysis in addition to creates authentic content material, together with video, interviews and articles. Unique content material created by investorideas is protected by copyright legal guidelines aside from syndication rights. Our web site doesn’t make suggestions for purchases or sale of shares, companies or merchandise. Nothing on our websites must be construed as a proposal or solicitation to purchase or promote merchandise or securities. All investing entails danger and doable losses. This web site is presently compensated for information publication and distribution, social media and advertising, content material creation and extra. Disclosure is posted for every compensated information launch, content material revealed /created if required however in any other case the information was not compensated for and was revealed for the only curiosity of our readers and followers. Contact administration and IR of every firm straight concerning particular questions.
Extra disclaimer data: https://www.investorideas.com/About/Disclaimer.asp Study extra about publishing your information launch and our different information companies on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
International traders should adhere to laws of every nation. Please learn Investorideas.com privateness coverage: https://www.investorideas.com/About/Private_Policy.asp
Buy a cannabis guest post on Investorideas.com
